Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
OSE Immunotherapeutics SA banner

OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 4.35 EUR -0.32% Market Closed
Market Cap: €97.7m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

OSE Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast OSE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSE is 15.16 EUR with a low forecast of 10.71 EUR and a high forecast of 22.05 EUR.

OSE Lowest Forecast
Wall Street Target
10.71 EUR
146% Upside
OSE Average Forecast
Wall Street Target
15.16 EUR
249% Upside
OSE Highest Forecast
Wall Street Target
22.05 EUR
407% Upside
Lowest
Price Target
10.71 EUR
146% Upside
Average
Price Target
15.16 EUR
249% Upside
Highest
Price Target
22.05 EUR
407% Upside
OSE Immunotherapeutics SA Competitors:
Price Targets
PTGX
Protagonist Therapeutics Inc
26% Upside
CSGP
CoStar Group Inc
81% Upside
APA
APA Corp (US)
-5% Downside
PTGX
Protagonist Therapeutics Inc
26% Upside
CSGP
CoStar Group Inc
81% Upside
APA
APA Corp (US)
-5% Downside

Revenue
Forecast

N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate of OSE Immunotherapeutics SA's revenue for the next 3 years is 18%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

What are analyst estimates?

See Also

Summary
OSE intrinsic value, competitors valuation, and company profile.
DCF Valuation
OSE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OSE stock valuation using valuation multiples.
Wall Street Estimates
OSE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OSE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is OSE's stock price target?
Price Target
15.16 EUR

According to Wall Street analysts, the average 1-year price target for OSE is 15.16 EUR with a low forecast of 10.71 EUR and a high forecast of 22.05 EUR.

What is OSE Immunotherapeutics SA's Revenue forecast?
Projected CAGR
18%

The compound annual growth rate of OSE Immunotherapeutics SA's revenue for the next 3 years is 18%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 318,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.